Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer’s revision label was updated from v3.6.2 to v3.6.3, indicating a small site update. This metadata change does not alter study information or how users interact with the page.SummaryDifference0.0%

- Check19 days agoChange DetectedThe footer now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects a small version update shown on the page.SummaryDifference0.0%

- Check26 days agoChange DetectedResults Submitted has been added to the study history, replacing No Results Posted. This reflects that the trial's results have been submitted for the record and are awaiting posting.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study history shows that enrollment has ended for this trial, and the record has been updated to a new revision (v3.6.0), replacing the previous version.SummaryDifference0.2%

- Check41 days agoChange DetectedRecord History now lists Revision: v3.5.5 as the current version, replacing the previous v3.5.4 entry.SummaryDifference0.0%

- Check62 days agoChange DetectedA new study record revision (v3.5.4) was added to the history, replacing the previous revision (v3.5.3).SummaryDifference0.0%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.